About Cell Systems
Cell Systems is a Healthcare company based in Kirkland (United States) founded in 1989 by Carl Soderland, and was acquired by Anabios in April 2023. Primary cells, culture media, and reagents are developed and manufactured. Cell Systems offers products and services including Primary Cells, Cell Culture Media, Reagents, Tissue Samples, and All-In-One Kits. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its competitors include BioLife Solutions, RoosterBio and Prolific Machines; 2 of its 3 listed competitors have raised funding.
Company details
Cell Systems is focused on developing primary cells, cell culture media reagents for the cell biology. They offer around 30 types of primary human cell types their complete medium kits for mesenchymal cells and cell lines, including human cells, embryonic and adult stem cells, etc. They also provide reagents for all steps of cell culture and cryopreservation. In addition, they are developing 3D cultures.
- Headquarters Kirkland, United States
- Founders Carl Soderland
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cell-systems.com
- Social LinkedIn
- Acquired by Anabios (Apr 2023)
Products & Services of Cell Systems
Cell Systems offers a comprehensive portfolio of products and services, including Primary Cells, Cell Culture Media, Reagents, Tissue Samples, and All-In-One Kits.
High-viability cells for advanced research experiments.
Nutrient media to support cell growth and viability.
Chemicals designed for cell biology research needs.
Samples for studying cellular structures and functions.
Comprehensive kits for optimized cell culture experiments.
Funding Insights of Cell Systems
- Total Rounds 1
- Last Round Unspecified — $200,000
- First Round $200,000
(May 2017)
All 1 funding rounds of Cell Systems with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2017 | $200,000 | Unspecified | – | – | – |
1 investors in total: 1 institutional.
Investors in Cell Systems
Cell Systems has secured backing from 1 investor. Prominent investors backing the company include Anabios.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Ex-vivo human tissue studies are performed for preclinical drug discovery. | 2009 | anabios.com | San Diego, United States |
Investor details for Cell Systems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cell Systems
1 people are tracked at Cell Systems (1 in leadership).
| Name | Role | Group |
|---|---|---|
Carl Soderland | Founder & President | Leadership |
Complete people profiles for Cell Systems
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cell Systems
3 dated milestones of Cell Systems across 34 years, from founding to its latest funding, stage changes and deals.
- Founded Cell Systems is founded.
- Funding First funding round of $200K.
- Exit Acquired by Anabios.
Competitors of Cell Systems
Cell Systems has 3 listed competitors in our database, 2 of them funded. They include BioLife Solutions, RoosterBio and Prolific Machines.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biolifesolutions.com | 1987 | Bothell, United States | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | ||
| roosterbio.com | 2012 | Frederick, United States | $38.41M | 69 | Developer of human mesenchymal stem cells and extracellular vesicles | |
| prolific-machines.com | 2020 | United States | $55M | Photomolecular biology platform is provided for controlling cellular functions dynamically. |
Detailed competitors of Cell Systems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cell Systems
The website of Cell Systems (cell-systems.com) receives about 5.2K visits a month.
- Monthly visits5.2K
▲ 41.1% vs previous month
Websites whose visitors overlap most with Cell Systems. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| google.com | 100% | 85.8B | #1 | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Cell Systems (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cell Systems
Complete news archive for Cell Systems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cell Systems
Cell Systems was founded in 1989 and raised its 1st funding round 28 years after it was founded.
Cell Systems is headquartered in Kirkland, United States. It is registered at Kirkland, Washington, United States.
Cell Systems is focused on developing primary cells, cell culture media reagents for the cell biology. They offer around 30 types of primary human cell types their complete medium kits for mesenchymal cells and cell lines, including human cells, embryonic and adult stem cells, etc. They also provide reagents for all steps of cell culture and cryopreservation. In addition, they are developing 3D cultures.
Cell Systems's top competitors include RoosterBio, Prolific Machines and BioLife Solutions.
Cell Systems offers Primary Cells, Cell Culture Media, Reagents, Tissue Samples, and All-In-One Kits.
Cell Systems has 1 investor. Key investors include Anabios.
Yes. Cell Systems was acquired by Anabios in April 2023.